Kalbe Farma
 | You can help expand this article with text translated from the corresponding article in Indonesian. (January 2024) Click [show] for important translation instructions.
|
 | This article needs additional citations for verification. (September 2012) |
 | |
| Company type | Public |
|---|---|
| IDX: KLBF | |
| Industry | |
| Founded | 10 September 1966 |
| Headquarters | Jakarta, Indonesia |
Area served | Worldwide |
Key people | Vidjongtius (CEO) Bernadette Ruth Irawati Setiady (President) |
| Products | Drugs, energy drinks, milk, baby food, healthy drinks, herbal supplements and nutrition products |
| Revenue |  Rp 26.261 trillion (2021) |
| Rp 3.208 trillion (2021) | |
| Total assets | Rp 25.667 trillion (2021) |
| Total equity | Rp 21.365 trillion (2021) |
Number of employees | 16,235 (2021) |
| Subsidiaries |
|
| Website | https://www.kalbe.co.id/ |
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966.[1] The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).[2]
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.[citation needed]
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion.
History
[edit]Kalbe Farma was founded on September 10, 1966, by 6 siblings, K.L. Tjoen, Theresia H. Setiady, Khouw Lip Swan, Khouw Lip Boen (Also Known As: Dr. Boenyamin Setiawan), Maria Karmila, and F. Bing Aryanto. Kalbe Farma first began operations in a house garage that was owned by the founders.
In May 2020, Kalbe Farma signed a Memorandum of Understanding with South Korean pharmaceuticals company Genexine Inc. to develop a vaccine for the new corona virus or COVID-19.[3]
References
[edit]- ^ "Our Story". Kalbe Malaysia. 2023-01-13. Retrieved 2024-06-24.
- ^ Grafton-Green, Patrick (1 October 2017). "Anti-abortion MP Jacob Rees-Mogg admits profits from abortion pills". Evening Standard. Retrieved 25 March 2020.
- ^ "Kalbe Farma and South Korea's Genexine to Start Human Trial for Covid-19 Vaccine". Jakarta Globe. Retrieved 2020-09-06.
External links
[edit]- 1966 establishments in Indonesia
- 1991 initial public offerings
- Indonesian companies established in 1966
- Manufacturing companies based in Jakarta
- Health care companies established in 1966
- Health care companies of Indonesia
- Pharmaceutical companies established in 1966
- Pharmaceutical companies of Indonesia
- Companies listed on the Indonesia Stock Exchange
- Companies in the IDX 30
- Companies in the LQ45